Bioinformatics & Genomics
| Opens resource in a 2nd browser window.
10th International Conference on Intelligent Systems for Molecular Biology
[ISMB] (Edmonton, Canada) August 3-7, 2002. The ISMB 2002 Conference provides a general forum for disseminating the latest developments in bioinformatics. It is a multidisciplinary conference that brings together scientists from molecular biology, medicine, computer science, mathematics and statistics. Its scope includes the development and application of advanced computational methods for biological problems at the levels of sequences, cells, organs, and organisms.
2nd ASM & TIGR Conference on Microbial Genomes.
[ASM & TIGR] (Las Vegas, Nevada) February 10-13, 2002. This conference will continue the successful collaboration of ASM and TIGR on the first ASM & TIGR Conference on Microbial Genomes. It will combine the scientific excellence of the two sponsoring organizations' previous meetings on the topic--ASM's Genomes 2000 and 1997 & 1998 Small Genomes Conferences with TIGR's annual Microbial Genomes Conferences.
Advances in Genome Biology and Technology
[GCORP] (Marco Island, FL) February 6-9, 2002. In 2002, AGBT will feature the expanding impact of genomic data on biological discovery across a wide variety of systems, including plants, microbes, and animals. Plenary sessions will highlight human genetics, mouse genetics, gene expression, and proteomic characterization.
[IBC] (San Diego, CA) October 16-18, 2002. IBC's Assay Development Conference has become a premier drug discovery event with an emphasis on robust and effective HTS assay development and the application of new screening technologies to reduce costs and accelerate discovery. A key part of the conference is the Case Study Session where scientists from major pharmaceutical laboratories present real data from real screening assays.
Beyond Genome: Information for the Computational Age
[Cambridge Healthtech Institute] (San Diego, CA) June 2-7, 2002. Beyond Genome is a weeklong event covering a number of computational tools used in the analysis and correlation of genomic data.
[BioFuture] (Vancouver, BC) November 21-22, 2002. Conference organizers are planning an exciting program covering a focused agenda to appeal to both the Scientific and Business Leaders. The program includes comprehensive sessions on current Technical and Management topics; as well as, a BioPartnering Forum by 20 up and coming Biotechnology Firms.
Bioinformatics & Genomics Research
[Cambridge Healthtech Institute] (San Diego, CA) June 4-5, 2002. The Bioinformatics & Genomics Research conference will focus on the tools needed to systematically link different types of datasets, and annotate the experimental data with clinical information.
Bioinformatics and Data Integration
[Barnett International] (Boston, MA) September 30 - October 1, 2002. This bioinformatics conference discusses strategies to extract and integrate data from a variety of genomic, interaction and biological pathway sources.
[Biotechfind.com] (Geneva, Switzerland) September 23-25, 2002. BioNetwork 2002 is the premier bio-partnering event for biotech and
pharma business development and licensing executives worldwide. With a
unique structure of industry case studies, roundtable discussion groups
and one-to-one meetings, attendees will hear the partnering strategies
of big pharma through to mid-sized biotechs.
[Duke Bioinformatics Shared Resources] CAMDA1 was founded to provide a forum to critically assess different techniques used in microarray data mining. It aims to establish the state-of-the-art in microarray data mining, as well as identify progress and highlight the direction for future effort.
Top of Page
Cell-Based Microarrays and High-Content Screening
(San Diego, CA) March 18-22, 2002. This conference will cover applications for various cell-based assay technologies, including high content cellular assays and emerging miniaturized platforms for automated electrophysiology and high throughput screening.
Chemical Genomics Strategies toward Concurrent Target Validation & Lead Discovery Optimization
[IBC] (Philadelphia, PA) May 30-31, 2002. This inaugural conference will not only provide an up-to-date look at the latest tools, but also actual case studies of chemical genomics applications.
[Cambridge Healthtech Institute] (Philadelphia, PA) May 6-8,2002. This conference will showcase cheminformatic tools for storage, design and mining of chemical databases/information and present case examples of its success in lead identification and optimization.
Chips To Hits 2002
[IBC] (Philadelphia, PA) October 28 - November 1, 2002. The event brings together industry and academia to address technology and application of microarrays, protein arrays, microfluidics, sample prep, data/imaging analysis and emerging technologies in the field.
Data Visualization and Interpretation
[Cambridge Healthtech Institute] (Washington D.C.) September 12-13, 2002. Data analysis involves visual, as well as statistical, understanding. Today complete biological data analysis involves a team effort including biological researchers, statisticians, bioinformaticists, database developers, and software engineers. This program is designed to incorporate each specialty into a comprehensive unit to produce yet another beneficial avenue for understanding the overwhelming information produced by biologic research.
Drug Discovery Informatics
[ACI] (Scottsdale, AZ) January 23-25, 2002. Senior level conference with case studies covering why integrating Bio&Chem Informatics is vital to streamlining the drug discovery process.
Emerging Microarray Technologies and Application
(San Diego, CA) March 18-22, 2002. This is the first meeting to recognize and combine the most promising areas of scientific advancements, therapeutic applications, and commercial developments in microtechnology. This five-day meeting features the latest research in the following three areas: Protein Microarrays, Cell-Based Microarrays and High-Content Screening, and Microarrays for Diagnostics.
[IBC] (San Francisco, CA) March 4-6, 2002. IBC's World Congress on Enzyme Technologies is driven by this intersection of biology and engineering, and provides a showcase for both industry scientists and executives who want to identify and discuss the latest trends, technologies, techniques and products in this growing industry.
Gene Functional Analysis
[Cambridge Healthtech Institute] (Santa Clara, CA) February 28 - March 1, 2002. Various approaches to modeling pathways will be addressed, along with the technical hurdles and accomplishments deployed towards that goal.
Genome Sequencing and Analysis Conference
[TIGR] (Boston, MA) October 2-5, 2002. Attendees from around the world will gather to discuss recent advances within the field of genomics. International experts from academia, government and the private sector
will be represented during GSAC's plenary and concurrent symposia. These sessions will highlight topics such as RNA interference, advances
in genomes of multicellular and single cell organisms, microarray data analysis, evolution of genomes and genome structures.
Top of Page
[Cambridge Healhtech Institute] (Santa Clara, CA) February 23-March 1, 2002. "Cambridge Healthtech Institute's Genome Tri-Conference is the premier industry event for all players in the genomics field. Kicking off the Tri-Conference is Genomic Partnering, providing a platform for early-stage companies to present cutting-edge genomic technologies. The core conference, Human Genome Discovery, highlights important advances in the rapidly developing genomics area which will revolutionize the field of medicine. Rounding out the week is coverage of developments in the increasingly important field of Gene Functional Analysis."
[Cambridge Healthtech Institute] (Santa Clara, CA) February 23-24, 2002. This platform will provide a platform for early-stage companies to present cutting-edge genomic technologies.
Genomics on Target: From Function to Validation
[Cambridge Health Institute] (Boston, Massachusetts) November 18-21, 2002. This conference is divided into four programs: Functional Genomics, Chemical Genomics, High-Throughput Target Validation, and Genomic Animal Models. Genomics on Target boasts over twenty-five pharmaceutical company speakers, and over eighty presentations.
G-Protein Coupled Receptors
[IBC] (San Diego, CA) October 14-16, 2002. The potential for greater specificity in regulating disease and for reduced side effects, has made GPCRs one of the richest targets in history for drug discovery. Despite the wide variety of GPCR-based drugs in the market today, these receptors remain the most important target class for research among pharmaceutical companies and research laboratories. IBC's GPCR conference will feature a 2-day focus on key insights into the biology, technology and mechanisms of GPCRs, and a 3rd day specific emphasis on Cell-based Assays.
High Performance Computing - CANCELLED
[Cambridge Healthtech Institute] (La Jolla, California) January 14-15, 2002. This meeting seeks to cover issues in strategic applications for genomics and proteomics for biotech, pharma, software, and
hardware engineers, for application specialists, and for anyone who envisions the marriage of supercomputers and the life sciences.
Human Genome Discovery
[Cambridge Healthtech Institute] (Santa Clara, CA) February 25-27, 2002. This conference will explore the world of information technology that is impacting genomics and the life-science industry as a whole, as well as the latest efforts to create operating systems for biology.
Human Proteome Project
[Human Proteome Organization] (San Diego, CA) January 9-11, 2002. The reason for creating HUPO is to assist in increasing the awareness of this discipline of science across society, particularly with regard to the Human Proteome Project, and to engender a broader understanding of the importance of proteomics and the opportunities it offers in the diagnosis, prognosis, and therapy of disease.
IBC Biochip Technologies Conference - Chips To Hits
[IBC] (Philadelphia, PA) October 27-31, 2002. Chips to Hits, produced and organized by IBC USA Conferences, is the most respected independent event dedicated to Microarray and Microfluidic new technology and applications for the pharmaceutical and biotech industries. Again, this year the event will be held in Philadelphia,
PA, providing key access to the Eastern Seaboard's technology and pharmaceutical belt. The
event provides an educational and commercial forum for pharmaceutical, biotechnology and related vendor companies to discuss new technologies and their applications.
Identifying & Validating Drug Targets through Genomics
[Strategic Research Institute] (Princeton, NJ) March 11-12, 2002. Topics to be addressed include: SNP Analysis & Genome Scans, Use of Key Animal Models, In-Vivo Functional Genomics, Antisense Functional Genomics, Engineered Transcription Factors, Ultra-Large HTP Libraries, DNA Microarrays, and Genomic Variation Information & Bioinformatics
Impact of Genomics on Medicine
[CHI] (Munich, Germany) May 13-14, 2002. This meeting will highlight the importance of a genomic approach to drug development and estimate the actual benefit of integrating genomic data into clinical practice.
Top of Page
In Silico Biology
[Cambridge Healthtech Institute] (San Diego, CA) June 2-3, 2002. This conference will showcase examples and applications of computational modeling of cells, tissues, and disease.
Integrated Bioinformatics: High-Throughput Interpretation of Pathways and Biology
(Zurich, Switzerland) January 14-16, 2002. Topic areas include: Statistical Analysis of Microarray data, Computational Challenges in Genomic and Proteomic Data, Engineering Protein Networks, Pathway Informatics, and Linking Gene Expression with Clinical Outcomes.
International Conference on Magnetic Resonance in Biological Systems
[ICMRBS] (Toronto, Ontario, Canada) August 25 - 30, 2002, all technical sessions, posters, and exhibits will be at the Fairmont Royal York Hotel, 100 Front Street West, Toronto, Ontario, Canada.
Ion Channel Drug Targets
[IBC] (San Diego, CA) October 14-16, 2002. Ion channels continue to be a drug target class of high interest to the pharmaceutical industry. Drug discovery for therapeutic products to manage pain and various psychiatric indications remain the focus of current ion channel research. This conference presents emerging ion channel research findings on several ion channel types. Presentations cover the genomics and cloning of ion channels, the biophysics of ion channel structure and function, as well as the physiology and pharmacology of ion channels.
Lab-on-a-Chip and Microarrays
[Cambridge Healthtech Institute] (Zurich, Switzerland) January 14-16, 2002. Innovations in technology and the resulting applications of lab-on-a-chip and microarray technologies re the focus of this conference. Topic areas includes: New insights in biology through gene expression studies, exploitation of gene expression know-how, Lab-on-a-Chip and Microarray applications in the diagnostic field, Lab-on-a-Chip in Action: Point of need testing, and Dissecting signaling pathway signatures from microarray data.
Microarray Data Analusis
[Cambridge Healthtech Institute] (Washington D.C.) September 10-11, 2002. Microarrays have exploded in the field of biological research. In fact, over 80 percent of laboratories using microarrays expect to increase their utilization over the next year. However, with the "boom" of the technology also comes the need for careful navigation through interpretation of the data minefield. The facilitation of adoption of standards for microarray experimental annotation, data representation, and the introduction of standard experimental controls and data normalization is critical for the resulting "boom" to be either destructive or productive.
Microarrays for Diagnostics
(San Diego, CA) March 18-22, 2002. Leading academic and industry experts will explore the latest in technology, applications, regulatory challenges, as well as alternative technologies for diagnostics.
Microfluidics 2002 Revolutionizing Drug Discovery, Diagnostics & Therapeutics
[IBC] (San Francisco, CA) September 18-20, 2002. The beauty and inspiration of Microfluidics lie in its ability to miniaturize, integrate and automate the work of biologists, chemists and engineers. Just as integrated circuits revolutionized the electronics industry in the 1960s, Microfluidics is said to transform biochemical analysis and high throughput screening, creating dramatic breakthroughs in drug discovery, diagnostics and proteomics.
Model Organisms for Drug Discovery
[IBC] (Boston, MA) August 8-9, 2002. Model organisms are finding a growing role in identifying and validating targets, in screening for lead compounds and in drug profiling. This conference focuses on the uses of model organisms to advance novel chemical entity discovery.
O'Reilly Bioinformatics Technology Conference
[O'Reilly & Associates] (La Paloma Resort, Tucson, Arizona) January 28-31, 2002. A Bioinformatics Technology Conference that will explore the engineering and tool-building aspects of bioinformatics.
Top of Page
[IBC Drug Discovery Series] (San Francisco, CA) January 23-25, 2002. This conference will cover Consumer Empowerment/Public Policy in Healthcare Decisions, Implementation and Application of Personalized Medicine, Investment Opportunities, Creative Partnering/Deal Making, State-of-the-Art Technologies, and Genetic Patenting Perspectives.
Pharmacogenomics & SNPs
[Strategic Research Institute] (Newark, New Jersey) January 28-29, 2002. The conference is organized into four sections: SNPs & Disease: The Future of Medicine, New Drug Targets: SNP Identification in Disease-Causing Genes, Core Technologies for SNP Discovery & Analysis, and Case Studies: Applications of Pharmacogenomic Technologies in Drug Development.
[CHI] (Munich, Germany) May 15-16, 2002. Coding variation directly impacts how the body handles drugs. What is significant is the extent to which this information can be sought out and used in rational drug design and delivery. As the jury deliberates, evidence accumulates to show that the market will be the final arbiter. North America came out ahead in the race to map the human genome, but can Europe take the lead by implementing this information faster to elucidate disease etiology and protein function, and to improve the drug discovery development process?
Plant, Animal and Microbe X Genomes Conference
[Scherago International] (San Diego, CA) January 12 - 16, 2002. A large international annual meeting that focuses on applied plant and animal genomics.
[IBC] (San Francisco, CA) June 24-26, 2002. Biology has entered a new era. "The biggest revolutions in biology are emerging from disciplines not originally considered biological: from engineering, technology and computer science," said Dr. Shankar Subramaniam of the University of San Deigo. This, is the challenge and transformation of the new dogma of science.
[Cambridge Healthtech Institute] (San Diego, California) January 7-8, 2002. Numerous technical obstacles, such as optimizing protein immobilization or selection of protein-binding ligands, strategies for extending the limits of detection, and novel applications of this exciting technology, are among the issues that will be discussed in detail during this conference
[Cambridge Healthtech Institute] (San Diego, California) January 7-8, 2002. This conference will explore the newest data and technologies relating to the expression and characterization of proteins for biological understanding and therapeutics.
Protein Informatics From Databases to Prediction
[Cambridge Healthtech Institute] (San Diego, California) January 13-14, 2003. Extracting the most value from proteomic data comes from being able to better understand and model biology, pathways, and targets to facilitate diagnostic and therapeutic development. CHI's Protein Informatics conference will provide in-depth coverage of the new computational methods and in silico tools necessary to deal with the flood of proteomic data.
The Protein Information Week
[Cambridge Healthtech Institute] (San Diego, California) January 7-11, 2002. Events include a Protein Arrays meeting, January 7-8. The conference runs concurrently with the Fifth Annual Protein Expression meeting on January 7-8. The final leg is the Second Annual Human Proteome Project, Januay 9-11, 2002.
[IBC] (Boston, MA) September 9-10, 2002. Target Validation, Drug discovery and Clinical Development of Kinase Therapeutics. Attend IBC's 2nd Protein Kinases conference and you will come away with a greater understanding of how pharmaceutical companies are actively developing kinase inhibitors that are implicated in various disease states.
Top of Page
[March 18-19, 2002.] (San Diego, CA) This conference will cover how proteome chips are being used by for global analysis of protein activities, how Oxford Glycosciences utilizes protein chip assays in their proteomics projects, and the latest application of protein arrays including: Protein profiling using antibody microarrays and how cell microarrays can be used as protein microarrays.
[Cambridge Healthtech Institute] (San Diego, CA) June 6-7, 2002. Proteomics is being held with the 11th Annual Bioinformatics and 4th Annual In Silico Biology as part of CHI's BEYOND GENOME meeting.
Proteomics Delivering New Routes to Drug Discovery
[IBC] (Philadelphia, PA) May 6-9, 2002. IBC's Annual Proteomics 2002 is the premier event designed to address the critical elements that are driving this field towards drugable targets. This event gives you expert views on the latest tools, techniques and technologies impacting Proteomics analysis, discovery, and integration. This conference delivers cutting-edge presentations, posters, and technology workshops to educate and stimulate discussion on various important topics.
Ressearch, Technologies, and Applications in Biodefense
[Cambridge Healthtech Institute] (McLean, Virginia) November 4-5, 2002. Knowledge and understanding gained through advances in biotechnology can be leveraged in biodefense research to protect humans, animals, and agricultural crops against intentional use of pathogens. This conference will present the latest research and technologies to improve specificity, sensitivity, and speed for detecting, identifying, and characterizing pathogens. It will also address efforts to create novel vaccines and therapeutics, to characterize host cell response and stimulate innate immunity, and to develop effective decontamination methods.
ScreenTech Screening for Success
[IBC] (San Diego, CA) March 4-6, 2002. A conference that shows how to succeed in developing new drug candidates through high-throughput screening and miniaturized technologies.
TIDES 2002: Oligonucleotide and Peptide Technology Conferences
[IBC] (Las Vegas, NV) May 6-8, 2002. Hear all about the planning for FDA approval of G3139 production. Discuss scale-up issues, production progress and the effect T-20 has had on raw material markets.
TRANSCRIPTOME 2002: From Functional Genomics to Systems Biology
[TIGR] (Seattle, Washington) March 10-13, 2002. This year's meeting will attempt to highlight the basic mechanisms by which cells mediate their growth, function, and metabolism, to examine tools and techniques for exploring gene expression, and to look to future applications.